Congo’s Ebola crisis has become a powerful symbol of global health inequality. The Democratic Republic of the Congo is facing its largest Ebola epidemic on record, with more than 6,000 confirmed cases and over 3,000 deaths since the outbreak was declared in mid-May 2026. The disease has spread through 60 health zones in six provinces, while health authorities and international organisations struggle to track every chain of transmission.
The latest official figures reported by Congolese authorities show 6,186 confirmed cases, 3,007 deaths and 1,409 recoveries. A further 830 patients were in isolation or treatment facilities. The resulting case-fatality rate is approximately 48.6%, although figures continue to change as authorities reconcile data, investigate suspected infections and improve reporting systems.
The speed of the epidemic has alarmed the United Nations, the World Health Organization and Africa CDC. The UN’s Emergency Relief Coordinator, Tom Fletcher, warned that
“the response is growing and has been scaled up, but the virus is moving faster.”
He added,
“Unless we scale up urgently, more lives will be lost and the threat will grow.”
That warning goes beyond the immediate question of whether medical teams are present on the ground. It raises a wider political question: why does the international system repeatedly wait for an African health emergency to become catastrophic before mobilising the resources needed to prevent it?
The geography of inequality
The outbreak is caused by the Bundibugyo virus, a species of Ebola distinct from the Zaire ebolavirus associated with earlier outbreaks and the licensed Ervebo vaccine. It was first reported in Ituri Province, but transmission has expanded to North Kivu, Haut-Uele, Tshopo, South Kivu and Bas-Uele.
Ituri remains the epicentre, with more than 5,000 cases. North Kivu has also suffered a heavy burden, while other provinces demonstrate the geographic expansion of the epidemic. The affected territory covers approximately 240,000 square kilometres, roughly the size of the United Kingdom.
This geography matters because the outbreak is unfolding in areas where healthcare access is already fragile. More than 26 million people in the DRC face acute food insecurity, and Ituri hosts approximately one million internally displaced people. Many communities live in overcrowded settlements with limited water, sanitation and healthcare services.
The country’s eastern provinces are also affected by armed conflict, including clashes involving government forces, Rwanda-backed M23 rebels, Ugandan troops and the Allied Democratic Forces. Violence restricts the movement of health workers, disrupts supply routes and makes it dangerous to reach suspected cases or conduct safe burials.
The result is a public-health emergency layered on top of displacement, hunger and insecurity. As Fletcher put it,
“It is not simply a health emergency. It is also a humanitarian emergency layered onto many existing humanitarian emergencies.”
That context is often missing from international coverage. Ebola is presented as a virus that must be contained, but containment is impossible when communities cannot safely access clinics, when families are displaced repeatedly and when health workers cannot reach affected populations without security guarantees.
A record outbreak with familiar causes
The DRC has experienced 17 Ebola outbreaks since the virus was identified in 1976. The current epidemic is the country’s largest, regardless of Ebola species. In its first 100 days, it recorded 5,515 cases and 2,642 deaths. By early September, the total had climbed to more than 6,100 cases and 3,000 deaths.
The comparison with West Africa’s 2014–2016 Ebola epidemic is revealing. During the first 100 days of that crisis, WHO recorded 635 cases and 399 deaths across Guinea, Liberia and Sierra Leone. The present DRC outbreak has grown far more rapidly during the same period.
The difference is not simply the result of a more dangerous virus. It reflects the conditions in which the virus is spreading. Conflict, weak infrastructure, delayed diagnosis, population displacement and low trust in institutions all allow transmission chains to continue.
WHO Director-General Tedros Adhanom Ghebreyesus warned that
“until every chain is found and broken, the epidemic will continue and will continue to pose a threat to DRC, its neighbours and the region as a whole.”
He also said that many deaths involved people who were not on lists of known contacts, indicating that response teams were missing chains of transmission.
This is one of the most disturbing features of the epidemic. Contact tracing is among the most effective tools for controlling Ebola, yet many cases are appearing outside known surveillance networks. Health authorities cannot isolate or monitor people they do not know are exposed.
Tedros also warned that unsafe burials were continuing. Funeral practices involving physical contact with the bodies of deceased people can transmit Ebola, particularly when families are unable to access safe and dignified burial services. The problem is not a lack of scientific knowledge; it is the failure to make safe services accessible, trusted and culturally respectful.
The vaccine dilemma
The most visible contradiction in Congo’s Ebola crisis is the existence of an Ebola vaccine that may not protect against the virus currently circulating.
Ervebo is licensed for Ebola disease caused by the Zaire species. The present outbreak involves Bundibugyo virus. WHO has reviewed additional animal, immunological and observational evidence and concluded that some findings suggest possible cross-protection, but the available evidence remains insufficient to establish clinically meaningful protection in humans.
WHO’s updated guidance recommends using Ervebo only within research protocols. It calls for a ring-randomised controlled trial to generate reliable evidence while continuing proven measures such as testing, isolation, contact tracing, infection prevention and safe burials.
This creates an ethical dilemma. If the vaccine might offer protection, delaying its deployment could expose healthcare workers and contacts to unnecessary risk. But if it is used without clear communication about its uncertain effectiveness, communities could be given false confidence.
The DRC has begun vaccinating frontline and healthcare workers. An initial supply of 70,000 doses has been approved, with approximately 50,000 doses intended for frontline and healthcare workers and 20,000 reserved for a Phase 3 clinical trial.
The policy is defensible only if it remains transparent. Congolese health workers and communities must be told that Ervebo is not a proven Bundibugyo vaccine. They must also receive protective equipment, training and clinical support rather than being asked to rely on an uncertain vaccine while working in unsafe facilities.
The deeper injustice is that research on a virus affecting African communities is being conducted during a lethal emergency because the world did not develop adequate Bundibugyo-specific vaccines and treatments before the crisis. The uncertainty is scientific, but its consequences are political.
Health workers cannot replace health systems
Healthcare workers are central to the response and among those most exposed to infection. Early in the outbreak, the deaths of health workers helped trigger international concern about the possibility of transmission inside medical facilities.
A health worker’s risk does not disappear because a vaccine trial begins. Effective protection also depends on triage, personal protective equipment, infection-prevention protocols, rapid testing, safe referral systems and adequate staffing.
The international community often describes African health workers as heroes. That language can be respectful, but it can also obscure a more uncomfortable truth: health workers should not have to compensate through courage for chronic underinvestment.
The current response has expanded surveillance, laboratories, isolation facilities, treatment centres and contact tracing. However, the results remain below the level required to stop the epidemic. A CDC analysis found that response performance remained below established targets across five critical indicators: alerts for suspected cases, contact tracing, laboratory testing, isolation and safe burials.
These are not abstract administrative shortcomings. Every delayed alert creates more opportunities for transmission. Every missed contact extends an invisible chain. Every unavailable laboratory result increases the chance that an infected person will remain in the community. Every unsafe burial can turn grief into another outbreak event.
Treatment, research and the cost of delay
There is no approved Bundibugyo-specific vaccine or treatment that has demonstrated effectiveness in humans. As a result, early diagnosis and high-quality supportive care remain essential.
WHO-sponsored researchers are conducting the PARTNERS clinical trial to investigate treatments for Bundibugyo virus disease. The trial began enrolling patients on July 2 and had included more than 250 confirmed patients across three clinical-management facilities in Ituri by late August.
Historical outbreaks recorded case-fatality rates of approximately 30% in Uganda and 50% in the DRC. North Kivu has reported a fatality ratio of approximately 68%, although investigators are still examining the reasons for that unusually high figure.
Fatality statistics are shaped by more than the characteristics of the virus. They also reflect how quickly people reach care, whether treatment centres have adequate supplies, whether patients are malnourished and whether health workers can safely operate.
For a person in a wealthy country, an Ebola diagnosis may lead to rapid laboratory confirmation, specialised care and evacuation to a well-equipped facility. For someone in a remote Congolese community, the same diagnosis may come after days of travel, several healthcare visits and exposure to an already overstretched system. Disease severity is biological, but survival is also political.
The price of insufficient financing
The funding gap is one of the clearest measures of global health inequality. The UN says the DRC’s government-led Ebola response plan is seeking $1.3 billion, while a $1.1 billion gap remains.
This means the international system is asking a country confronting the largest Ebola outbreak in its history to finance a response that is far beyond its domestic capacity. The DRC is simultaneously managing conflict, displacement, food insecurity and other humanitarian emergencies.
The lack of funding also threatens neighbouring countries. The UN’s International Organization for Migration has conducted nearly 23 million health screenings in the DRC and neighbouring countries, helping monitor population movements and identify possible cases. The UN has allocated more than $57 million from its Central Emergency Response Fund for Ebola response and preparedness in the DRC and nearby states.
These measures are important, but they do not match the scale of the emergency. Funding that arrives late is less effective and more expensive than early investment. A response that cannot maintain contact tracing, transport, treatment and community outreach will continue to fall behind the virus.
Fletcher’s assessment is both practical and moral:
“We have the experience, the tools and extraordinary people risking their lives to stop this epidemic. What we need now is political will, access and resources.”
He added,
“We have beaten Ebola before, and we can do it again.”
The problem is not that the world lacks knowledge. It is that global priorities determine where knowledge becomes action.
Regional risks and Uganda’s lesson
The WHO has assessed the risk as very high within the DRC, high for countries sharing land borders and low for the rest of Africa and the world. Uganda, South Sudan and the Central African Republic face particular risks because of cross-border movement, trade, displacement and informal routes that bypass official screening.
Uganda provides an important example of what rapid action can achieve. The country recorded 20 cases between May and June, but WHO declared the outbreak over on August 25 after 42 days without a new confirmed case. Uganda’s containment relied on rapid detection, laboratory confirmation, contact tracing, isolation, clinical care, infection prevention, community engagement and strengthened surveillance.
The contrast should not be interpreted as evidence that Uganda simply responded better than the DRC. The two countries faced different geographical, security and institutional conditions. Rather, Uganda demonstrates that Ebola can be controlled when essential response tools are available, coordinated and sustained.
The DRC needs the same level of support, adapted to its own realities. A strategy designed for a stable urban environment cannot simply be applied to remote communities affected by armed groups and displacement.
The United Nations and the politics of attention
The United Nations has warned that the epidemic is accelerating while the international response remains behind. The UN Secretary-General described it as the fastest-growing Ebola epidemic on record and said,
“The virus is growing faster and wider than the response to contain it, but it can be stopped.”
He also warned that
“international attention, political focus and resources are still lagging behind the reality unfolding on the ground.”
His most striking phrase was a warning that the world must overcome another pathogen: “the virus of indifference.”
That language matters because global health emergencies are not judged only by their medical severity. They are also judged by their geopolitical visibility. Epidemics that threaten wealthy populations often receive rapid funding, high-level political attention and accelerated research. Epidemics that remain concentrated among poor and displaced communities are more likely to be framed as local tragedies.
The international community should not wait for infections to reach Europe, North America or other influential regions before treating the crisis as urgent. The risk outside Africa may currently be low, but the moral responsibility to act does not depend on a threat to wealthy countries.
What a fair response requires
A credible response to Congo’s Ebola crisis must begin with immediate financing, but it cannot end there. Donors should fully fund the DRC-led plan, support local health workers, expand laboratories and ensure that communities can access treatment without facing violence or unaffordable travel.
The United Nations and regional partners must also press for humanitarian access and the protection of medical personnel. Security arrangements should enable health teams to reach displaced communities, mining areas and remote settlements without making assistance dependent on military control.
Research must focus on Bundibugyo virus disease, including vaccines, treatments and diagnostic tools. Clinical trials should be conducted ethically, with informed consent and clear public communication. The deployment of Ervebo must not be used to avoid investment in a vaccine specifically designed for Bundibugyo virus.
Most importantly, the response must treat Congolese communities as partners rather than passive recipients of international intervention. Safe burials, contact tracing and vaccination succeed when people trust the institutions delivering them. Trust requires transparency, respect, protection from abuse and services that address everyday needs alongside the epidemic.
Congo’s Ebola crisis is not simply an infectious-disease emergency. It is a test of whether global health institutions can respond before inequality becomes a mass grave. Africa CDC Director-General Jean Kaseya acknowledged the scale of the challenge when he said,
“Despite the considerable efforts of the government and partners, we are not yet where we need to be.”
He also pledged,
“We will not relent until this outbreak is brought under control.”
That commitment must be matched by the governments, donors and institutions that possess the resources to change the trajectory of the epidemic. The DRC does not need sympathy after another thousand deaths. It needs political will, financing, access and scientific solidarity now.
Until that happens, Congo’s Ebola crisis will continue to expose a global health order in which protection is treated as a privilege, preparedness as an afterthought and African lives as a crisis only when the rest of the world begins to feel threatened.
